GUANGZHOU, China, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it plans to release its unaudited financial results for the second quarter of 2022 before the U.S. market opens on August 31, 2022. Following the release, company management will host a conference call at 8:30 a.m. ET (8:30 p.m. Hong Kong time) on the same day to discuss its financial results for the second quarter of 2022.
Burning Rock Provides Second Quarter 2022 Business Updates and Schedules Earnings Release on August 31, 2022
Globe Newswire -
Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Microsoft%20Corporation%20logo%20on%20phone-by%20rafapress%20via%20Shuterstock.jpg)
